e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Tuberculosis, hydatidosis, empty scheme and pleural disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The assessment of surgical treatment in pulmonary hidatidosis
L. N. Galie, N. S. Galie, E. Tabacu, R. D. Posea, E. Crisan (Bucharest, Romania)
Source:
Annual Congress 2005 - Tuberculosis, hydatidosis, empty scheme and pleural disease
Session:
Tuberculosis, hydatidosis, empty scheme and pleural disease
Session type:
Poster Discussion
Number:
3214
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. N. Galie, N. S. Galie, E. Tabacu, R. D. Posea, E. Crisan (Bucharest, Romania). The assessment of surgical treatment in pulmonary hidatidosis. Eur Respir J 2005; 26: Suppl. 49, 3214
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
The surgical treatment of pulmonary aspergillomas
Source: Eur Respir J 2001; 18: Suppl. 33, 459s
Year: 2001
Our experience in surgical treatment for pulmonary hydatidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 490s
Year: 2005
The assessment of pulmonary aspergiloma
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007
Treatment failure of nontuberculosis pulmonary disease after adjunctive surgical resection
Source: Virtual Congress 2021 – Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease
Year: 2021
When conservative surgery is sufficient in treatment of pulmonary aspergilloma ?
Source: Virtual Congress 2020 – Thoracic surgery: lung cancer and infectious disease
Year: 2020
Pulmonary denervation is a new alternative non-pharmacological treatment for residual pulmonary hypertension after pulmonary endarterectomy
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018
Role of pulmonary rehabilitation after bronchoscopic treatment of emphysema
Source: International Congress 2017 – Endoscopic lung volume reduction (EVLR) and targeted lung denervation (TLD)
Year: 2017
Pulmonary aspergilloma: clinical findings and surgical treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 274s
Year: 2006
Preoperative pulmonary risk assessment of pulmonary arterial hypertension in patients undergoing cardiac surgery
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Outcomes of surgical treatment of VSD with pulmonary hypertension
Source: International Congress 2018 – On the right path: understanding and improving the function of an overloaded right heart ventricle
Year: 2018
Surgical treatment of pleural complications of pulmonary hydatidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 344s
Year: 2002
Implementation of the autoangiotransplant for post-resection bronchial fistulae prevention among patients with pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 424s
Year: 2005
Predictors of clinical outcome in emphysema patients with atelectasis following endoscopic valve therapy
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015
Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment
Source: Eur Respir J 2013; 41: 302-308
Year: 2013
Surgical treatment of pulmonary tuberculosis
Source: Eur Respir Monogr 2013; 61: 20-36
Year: 2013
Validation of surgical management for patients with small pulmonary peripheral lesions
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010
The effectiveness of pulmonary rehabilitation including occupational therapy in patients with chronic pulmonary emphysema
Source: Eur Respir J 2002; 20: Suppl. 38, 376s
Year: 2002
Evaluation of various procedures in the diagnosis of pulmonary embolism
Source: Eur Respir J 2005; 26: Suppl. 49, 521s
Year: 2005
Safety of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
Complex treatment of widespread destructive pulmonary tuberculosis using innovative technology of the main bronchial stump treatment during pneumonectomy
Source: Virtual Congress 2021 – Rare thoracic surgical disease and the chest wall
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept